These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 9364083

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of bed nucleus of the stria terminalis and amygdala AMPA receptors in the development and expression of context conditioning and sensitization of startle by prior shock.
    Davis M, Walker DL.
    Brain Struct Funct; 2014 Nov; 219(6):1969-82. PubMed ID: 23934654
    [Abstract] [Full Text] [Related]

  • 3. Visual pathways involved in fear conditioning measured with fear-potentiated startle: behavioral and anatomic studies.
    Shi C, Davis M.
    J Neurosci; 2001 Dec 15; 21(24):9844-55. PubMed ID: 11739592
    [Abstract] [Full Text] [Related]

  • 4. Double dissociation in the neural substrates of acute opiate dependence as measured by withdrawal-potentiated startle.
    Harris AC, Atkinson DM, Aase DM, Gewirtz JC.
    Neuroscience; 2006 Dec 15; 139(4):1201-10. PubMed ID: 16600512
    [Abstract] [Full Text] [Related]

  • 5. Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli.
    Campeau S, Davis M.
    J Neurosci; 1995 Mar 15; 15(3 Pt 2):2301-11. PubMed ID: 7891168
    [Abstract] [Full Text] [Related]

  • 6. Involvement of subcortical and cortical afferents to the lateral nucleus of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli.
    Campeau S, Davis M.
    J Neurosci; 1995 Mar 15; 15(3 Pt 2):2312-27. PubMed ID: 7891169
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
    Walker D, Yang Y, Ratti E, Corsi M, Trist D, Davis M.
    Neuropsychopharmacology; 2009 May 15; 34(6):1533-42. PubMed ID: 19078950
    [Abstract] [Full Text] [Related]

  • 8. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.
    Walker DL, Ressler KJ, Lu KT, Davis M.
    J Neurosci; 2002 Mar 15; 22(6):2343-51. PubMed ID: 11896173
    [Abstract] [Full Text] [Related]

  • 9. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.
    Lee Y, Davis M.
    J Neurosci; 1997 Aug 15; 17(16):6434-46. PubMed ID: 9236251
    [Abstract] [Full Text] [Related]

  • 10. Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression.
    Walker DL, Paschall GY, Davis M.
    Learn Mem; 2005 Aug 15; 12(2):120-9. PubMed ID: 15774945
    [Abstract] [Full Text] [Related]

  • 11. Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats.
    Schweimer J, Fendt M, Schnitzler HU.
    Eur J Pharmacol; 2005 Jan 10; 507(1-3):117-24. PubMed ID: 15659301
    [Abstract] [Full Text] [Related]

  • 12. Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle.
    Zhao Z, Yang Y, Walker DL, Davis M.
    Neuropsychopharmacology; 2009 Jan 10; 34(2):331-40. PubMed ID: 18418359
    [Abstract] [Full Text] [Related]

  • 13. Lesions of the central nucleus of the amygdala block conditioned excitation, but not conditioned inhibition of fear as measured with the fear-potentiated startle effect.
    Falls WA, Davis M.
    Behav Neurosci; 1995 Jun 10; 109(3):379-87. PubMed ID: 7662148
    [Abstract] [Full Text] [Related]

  • 14. Amygdaloid GABA, not glutamate neurotransmission or mRNA transcription controls footshock-associated fear arousal in the acoustic startle paradigm.
    Van Nobelen M, Kokkinidis L.
    Neuroscience; 2006 Jun 10; 137(2):707-16. PubMed ID: 16289581
    [Abstract] [Full Text] [Related]

  • 15. Fear-potentiated startle in rats is mediated by neurons in the deep layers of the superior colliculus/deep mesencephalic nucleus of the rostral midbrain through the glutamate non-NMDA receptors.
    Zhao Z, Davis M.
    J Neurosci; 2004 Nov 17; 24(46):10326-34. PubMed ID: 15548646
    [Abstract] [Full Text] [Related]

  • 16. Evidence of contextual fear after lesions of the hippocampus: a disruption of freezing but not fear-potentiated startle.
    McNish KA, Gewirtz JC, Davis M.
    J Neurosci; 1997 Dec 01; 17(23):9353-60. PubMed ID: 9364080
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological analysis of fear-potentiated startle.
    Davis M.
    Braz J Med Biol Res; 1993 Mar 01; 26(3):235-60. PubMed ID: 8257926
    [Abstract] [Full Text] [Related]

  • 18. Expression and conditioned inhibition of fear-potentiated startle after stimulation and blockade of AMPA/Kainate and GABA(A) receptors in the dorsal periaqueductal gray.
    Fendt M.
    Brain Res; 2000 Oct 13; 880(1-2):1-10. PubMed ID: 11032984
    [Abstract] [Full Text] [Related]

  • 19. Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle.
    Gewirtz JC, McNish KA, Davis M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May 13; 22(4):625-48. PubMed ID: 9682277
    [Abstract] [Full Text] [Related]

  • 20. Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm.
    Hitchcock J, Davis M.
    Behav Neurosci; 1986 Feb 13; 100(1):11-22. PubMed ID: 3954873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.